Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.12.2 (
MEK
)
18,161
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have isolated a mouse cDNA for a novel dual-specificity phosphatase designated
LDP-3
(
low-molecular-mass dual-specificity phosphatase 3
). The 450 bp open reading frame encodes a protein of 150 amino acids with a predicted molecular mass of 16 kDa. Northern blot and reverse transcription-PCR analyses show that
LDP-3
transcripts are expressed in almost all mouse tissues examined. In vitro analyses using several substrates and inhibitors indicate that
LDP-3
possesses intrinsic dual-specificity phosphatase activity. When expressed in mammalian cells,
LDP-3
protein is localized mainly to the apical submembrane area. Forced expression of
LDP-3
does not alter activation of ERK (extracellular-signal-regulated kinase), but rather enhances activation of JNK (c-Jun N-terminal kinase) and p38 and their respective upstream kinases
MKK4
(mitogen-activated protein kinase kinase 4) and
MKK6
in cells treated with 0.4 M sorbitol. By screening with a variety of stimuli, we found that
LDP-3
specifically enhances the osmotic stress-induced activation of JNK and p38.
...
PMID:Characterization of a novel low-molecular-mass dual-specificity phosphatase-3 (LDP-3) that enhances activation of JNK and p38. 1528 13